Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
21.08
+0.42 (2.03%)
Aug 5, 2026, 4:00 PM EDT - Market closed
Sabra Health Care REIT Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Sabra Health Care REIT stock has a consensus rating of "Buy" and an average price target of $22.71. The average 1-year stock price forecast is 7.73% higher than the current stock price, while the lowest is $19 (-9.87%) and the highest is $25 (+18.60%).
Price Target: $22.71 (+7.73%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Sabra Health Care REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 8 | 8 | 7 | 7 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 13 | 13 | 15 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 4, 2026 |
| Deutsche Bank | Deutsche Bank | Buy Maintains $22 → $25 | Buy | Maintains | $22 → $25 | +18.60% | Jul 22, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $25 | Buy | Reiterates | $25 | +18.60% | Jul 22, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Maintains $22 → $23 | Hold | Maintains | $22 → $23 | +9.11% | Jul 22, 2026 |
| Barclays | Barclays | Hold Maintains $21 | Hold | Maintains | $21 | -0.38% | Jul 22, 2026 |
Financial Forecast
Revenue This Year
898.12M
from 775.76M
Increased by 15.77%
Revenue Next Year
987.56M
from 898.12M
Increased by 9.96%
EPS This Year
0.67
EPS Next Year
0.76
from 0.67
Increased by 14.29%
EPS based on non-GAAP adjusted numbers.